Managed-care outcomes unknown in children with chronic diseases Newsletter Article 11 February 2013 Pages: 2 - 2
Enteroviral disease & pertussis costs indicate need for changes to therapy Gill Higgins Newsletter Article 11 February 2013 Pages: 3 - 4
Reasons for variation in the effects of practice guidelines Newsletter Article 11 February 2013 Pages: 4 - 4
Look towards improving healthcare quality while reducing costs Newsletter Article 11 February 2013 Pages: 4 - 5
Barrett’s oesophagus - is screening for cancer cost effective? Newsletter Article 11 February 2013 Pages: 5 - 5
News from the 133rd British Pharmaceutical Conference Newsletter Article 11 February 2013 Pages: 6 - 6
Vancomycin monitoring cost effective in febrile neutropenia Newsletter Article 11 February 2013 Pages: 7 - 7
Battle of docetaxel and paclitaxel in metastatic breast cancer Newsletter Article 11 February 2013 Pages: 7 - 7
Is immunisation against typhoid in military cost effective? Newsletter Article 11 February 2013 Pages: 8 - 8
Thrombectomy vs thrombolysis in dialysis graft thrombosis Newsletter Article 11 February 2013 Pages: 8 - 8
Medication and follow-up reduce idiopathic anaphylaxis costs Newsletter Article 11 February 2013 Pages: 10 - 10
Antineoplastics improve QOL in pancreatic and biliary cancers Newsletter Article 11 February 2013 Pages: 10 - 11
New AIDS therapies must not be withheld on cost grounds Newsletter Article 11 February 2013 Pages: 11 - 12